by Rich Weil, M.Ed., CDE Founder and Director Transformation Weight Control In this blog I am going to speak about the medications approved for weight loss called GLP-1s and GIP and how they help you lose weight
Healthy weight loss with either therapy requires careful monitoring and realistic goal setting
Whilst there is no confirmed causal link between retatrutide and serious cardiac events based on current data, the drug's pharmacological profile means that certain symptoms should never be ignored
Dysaesthesia has been reported in some clinical trials of semaglutide, including the STEP UP T2D trial of subcutaneous semaglutide, results of which showed that the adverse effect was more common with 7.2 mg doses (n=58 [18.9%] of 307) compared with 2.4 mg doses (n=five [4.9%] of 103)
GLP-1 receptor agonists reduce glucagon and glycogen secretion, inhibit appetite and slow gastric emptying [17] [18], creating a multifaceted approach to weight management that addresses both metabolic and behavioral components of obesity